Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease?
Boyer
James L
JL
Liver Center, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, 06520, USA. james.boyer@yale.edu
D000818:Animals; D002780:Cholestasis, Intrahepatic / Q000175:diagnosis / Q000628:therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D005500:Follow-Up Studies; D006801:Humans; D008107:Liver Diseases / Q000628:therapy*; D018160:Receptors, Cytoplasmic and Nuclear / Q000627:therapeutic use*; D018570:Risk Assessment; D016896:Treatment Outcome
D018160:Receptors, Cytoplasmic and Nuclear